RON is overexpressed in bladder cancer and contributes to tumorigenic phenotypes in 5637 cells

Por Chen, Jun-Feng, Yu, Bi-Xia, Ma, Liang, Lv, Xiu-Yi, Jiang, Jun-Hui, Ma, Qi
Publicado no Oncol Lett (2018)

Monoclonal antibody Zt/g4 targeting RON receptor tyrosine kinase enhances chemosensitivity of bladder cancer cells to Epirubicin by promoting G1/S arrest and apoptosis

Por Chen, Jun-Feng, Yu, Bi-Xia, Yu, Rui, Ma, Liang, Lv, Xiu-Yi, Cheng, Yue, Ma, Qi
Publicado no Oncol Rep (2017)

Anti-tumor effects of Atractylenolide I on bladder cancer cells

Por Yu, Rui, Yu, Bi-xia, Chen, Jun-feng, Lv, Xiu-yi, Yan, Ze-jun, Cheng, Yue, Ma, Qi
Publicado no J Exp Clin Cancer Res (2016)

Correction to: Anti-tumor effects of Atractylenolide I on bladder cancer cells

Por Yu, Rui, Yu, Bi-xia, Chen, Jun-feng, Lv, Xiu-yi, Yan, Ze-jun, Cheng, Yue, Ma, Qi
Publicado no J Exp Clin Cancer Res (2018)